Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Non Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05020392
What this trial is testing

Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaBurkitt LymphomaFollicular Lymphoma+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Looking for participantsNCT05615636
What this trial is testing

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Who this might be right for
Hodgkin LymphomaB-Cell LymphomaRelapsed B-cell NHL
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT06846463
What this trial is testing

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Who this might be right for
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University 21
Testing effectiveness (Phase 2)Study completedNCT01164267
What this trial is testing

Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)

Who this might be right for
Marginal Zone B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 30
Testing effectiveness (Phase 2)Looking for participantsNCT06213311
What this trial is testing

Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

Who this might be right for
B Cell Lymphoma
M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT00101244
What this trial is testing

SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+30 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00166439
What this trial is testing

Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma
Academic and Community Cancer Research United 50
Not applicableUnknownNCT04624971
What this trial is testing

A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab Era

Who this might be right for
Diffuse Large B Cell Lymphoma
Sun Yat-sen University 2,000
Testing effectiveness (Phase 2)Study completedNCT00406809
What this trial is testing

ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Chronic Lymphoid LeukemiaLymphoid MalignanciesNon-Hodgkin's Lymphoma+3 more
AbbVie (prior sponsor, Abbott) 81
Testing effectiveness (Phase 2)Looking for participantsNCT06839053
What this trial is testing

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaRecurrent Chronic Lymphocytic Leukemia+6 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01866839
What this trial is testing

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Who this might be right for
MDS (Myelodysplastic Syndrome)Myeloproliferative DisorderLymphoma, Non-Hodgkin+2 more
National Heart, Lung, and Blood Institute (NHLBI) 41
Early research (Phase 1)Ended earlyNCT03571828
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma(DLBCL)Mantle Cell Lymphoma (MCL)Follicular Lymphoma (FL)
Amgen 10
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Early research (Phase 1)Looking for participantsNCT04223765
What this trial is testing

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Who this might be right for
Mantle Cell LymphomaFollicular LymphomaSplenic Marginal Zone Lymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableNot Yet RecruitingNCT07592481
What this trial is testing

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Follicular Lymphoma ( FL)Waldenstrom Macroglobulinaemia+3 more
Centre Hospitalier de la côte Basque 40
Not applicableNot Yet RecruitingNCT07376330
What this trial is testing

Molecular and Cellular Characterization of MALT Lymphoma

Who this might be right for
MALT Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 400
Very early researchNot Yet RecruitingNCT05779930
What this trial is testing

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory+3 more
Nationwide Children's Hospital 12
Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Next Page